Refractory, Fatal Autoimmune Hemolytic Anemia Due to Ineffective Thymic-derived T-cell Reconstitution Following Allogeneic Hematopoietic Cell Transplantation for Hypomorphic RAG1 Deficiency

Overview

Journal Pediatr Blood Cancer

Specialties Hematology
Oncology
Pediatrics

Date 2022 Dec 30

PMID 36583469

Authors

Jennifer R Yonkof

Amrita Basu

Margaret T Redmond

Adam Kerry Dobbs

Ludmila Perelygina

Luigi D Notarangelo

Roshini S Abraham

Hemalatha G Rangarajan

Affiliations

Soon will be listed here.

Citing Articles

Case report: Identification of a Chinese patient with mutations initially presenting as autoimmune hemolytic anemia.

Chen X, Jiang C, Song W, Sun T, Yan J, Xu W Front Immunol. 2024; 15:1498066.

PMID: 39720732 PMC: 11666426. DOI: 10.3389/fimmu.2024.1498066.

CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.

Bowman S, Stanek J, Bajwa R, Polishchuk V, Abu-Arja R, Rangarajan H Clin Hematol Int. 2023; 5(2-3):155-164.

PMID: 37027103 PMC: 10241744. DOI: 10.1007/s44228-023-00042-w.

References

Notarangelo L, Kim M, Walter J, Lee Y . Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. 2016; 16(4):234-46. PMC: 5757527. DOI: 10.1038/nri.2016.28. View

Perelygina L, Chen M, Suppiah S, Adebayo A, Abernathy E, Dorsey M . Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies. PLoS Pathog. 2019; 15(10):e1008080. PMC: 6837625. DOI: 10.1371/journal.ppat.1008080. View

Lee Y, Frugoni F, Dobbs K, Walter J, Giliani S, Gennery A . A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2013; 133(4):1099-108. PMC: 4005599. DOI: 10.1016/j.jaci.2013.10.007. View

Schuetz C, Gerke J, Ege M, Walter J, Kusters M, Worth A . Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT. Blood. 2022; 141(7):713-724. PMC: 10082356. DOI: 10.1182/blood.2022017667. View

Buchbinder D, Hauck F, Albert M, Rack A, Bakhtiar S, Shcherbina A . Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders. J Clin Immunol. 2019; 39(1):81-89. PMC: 7739844. DOI: 10.1007/s10875-018-0581-0. View

Delmonte O, Schuetz C, Notarangelo L . RAG Deficiency: Two Genes, Many Diseases. J Clin Immunol. 2018; 38(6):646-655. PMC: 6643099. DOI: 10.1007/s10875-018-0537-4. View

Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L . Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998; 93(5):885-96. DOI: 10.1016/s0092-8674(00)81448-8. View

Farmer J, Foldvari Z, Ujhazi B, de Ravin S, Chen K, Bleesing J . Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019; 7(6):1970-1985.e4. PMC: 6612449. DOI: 10.1016/j.jaip.2019.02.038. View

Perelygina L, Faisthalab R, Abernathy E, Chen M, Hao L, Bercovitch L . Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity. Front Immunol. 2022; 12:796065. PMC: 8728873. DOI: 10.3389/fimmu.2021.796065. View

10.

Asai E, Wada T, Sakakibara Y, Toga A, Toma T, Shimizu T . Analysis of mutations and recombination activity in RAG-deficient patients. Clin Immunol. 2010; 138(2):172-7. DOI: 10.1016/j.clim.2010.11.005. View

11.

Nataraj R, Hiwarkar P, Bonney D, Campbell H, Jones S, Deambrosis D . B-cell depletion abrogates immune mediated cytopenia and rejection of cord blood transplantation in Hurler syndrome. Bone Marrow Transplant. 2021; 57(1):38-42. PMC: 8732280. DOI: 10.1038/s41409-021-01465-w. View

12.

John T, Walter J, Schuetz C, Chen K, Abraham R, Bonfim C . Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency. J Clin Immunol. 2016; 36(7):725-32. PMC: 5286911. DOI: 10.1007/s10875-016-0326-x. View

13.

Law J, Cowan M, Dvorak C, Musick L, Long-Boyle J, Baxter-Lowe L . Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution. Biol Blood Marrow Transplant. 2012; 18(11):1656-63. DOI: 10.1016/j.bbmt.2012.05.006. View